2023 annual financial data
Inovio Pharmaceuticals 2023 Revenue growth
Direct answer
Revenue growth was -91.89%.
Operating income was -143,940,028 USD and net income was -135,117,352 USD.
Operating cash flow was -124,365,551 USD.
Get free Inovio Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 832,010 USD
- Operating income
- -143,940,028 USD
- Net income
- -135,117,352 USD
- Operating cash flow
- -124,365,551 USD